Figure 3

Kaplan–Meier curve representing biochemical recurrence (BCR) for patients stratified according to ERG (upper panel) and tumor-associated trypsin inhibitor (TATI) (lower panel) expression. Neither ERG (log rank (Mantel–Cox), P=0.689) nor TATI (log rank (Mantel–Cox), P=0.447) turns out to be a significant predictor of BCR.